1. Home
  2. CTKB vs SOPH Comparison

CTKB vs SOPH Comparison

Compare CTKB & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.57

Market Cap

541.1M

Sector

Health Care

ML Signal

HOLD

Logo SOPHiA GENETICS SA

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$6.50

Market Cap

462.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTKB
SOPH
Founded
1990
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
541.1M
462.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CTKB
SOPH
Price
$4.57
$6.50
Analyst Decision
Hold
Strong Buy
Analyst Count
4
2
Target Price
$5.63
$7.50
AVG Volume (30 Days)
2.1M
387.6K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$193,015,000.00
N/A
Revenue This Year
$5.42
$23.09
Revenue Next Year
$7.03
$19.57
P/E Ratio
N/A
N/A
Revenue Growth
17.67
N/A
52 Week Low
$3.22
$2.92
52 Week High
$6.18
$6.50

Technical Indicators

Market Signals
Indicator
CTKB
SOPH
Relative Strength Index (RSI) 53.69 72.62
Support Level $4.17 $4.63
Resistance Level $4.78 N/A
Average True Range (ATR) 0.20 0.37
MACD -0.01 0.07
Stochastic Oscillator 42.27 87.71

Price Performance

Historical Comparison
CTKB
SOPH

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Share on Social Networks: